Figure 2 Figure 3 Meta-analysis of the outcome Pain relief with GLP-1 agonists versus placebo According to the results, ROSE-010 (100 g) considerably lowers the pain intensity when compared to a placebo
Related Stories Switching APOE4 to APOE2 in adult mice reduces Alzheimers pathology and improves memory Could GLP-1 drugs help prevent breast cancer
Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rnne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nhr J, Lu TT, Polex-Wolf J, Prevot V, Raun K, Simonsen L, Sun G, Szilvsy-Szab A, Willenbrock H, Secher A, Knudsen LB, Hogendorf WFJ
Among non-elderly adults with ESI (estimated to be 116.8 million from NHIS), 42%, or 49.3 million people, are clinically eligible for GLP-1 drugs